• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A novel differential diagnosis algorithm for chronic lymphocytic leukemia using immunophenotyping with flow cytometry.一种使用流式细胞术免疫表型分析的慢性淋巴细胞白血病新型鉴别诊断算法。
Hematol Transfus Cell Ther. 2023 Apr-Jun;45(2):176-181. doi: 10.1016/j.htct.2021.08.012. Epub 2021 Nov 29.
2
Which Markers Should the used for Diagnostic Chronic Lymphocytic Leukemia Immunophenotyping Scoring System by Flow Cytometry?流式细胞术用于诊断慢性淋巴细胞白血病免疫表型评分系统时应使用哪些标志物?
Clin Lab. 2019 Nov 1;65(11). doi: 10.7754/Clin.Lab.2019.190316.
3
Application of modified Matutes score containing CD200 in diagnosis of chronic lymphocytic leukemia.改良 Matutes 评分中包含 CD200 在慢性淋巴细胞白血病诊断中的应用。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Dec 28;47(12):1689-1694. doi: 10.11817/j.issn.1672-7347.2022.220302.
4
A new score including CD43 and CD180: Increased diagnostic value for atypical chronic lymphocytic leukemia.一种包含 CD43 和 CD180 的新评分:提高了非典型慢性淋巴细胞白血病的诊断价值。
Cancer Med. 2021 Jul;10(13):4387-4396. doi: 10.1002/cam4.3983. Epub 2021 Jun 1.
5
The Role of CD200 and CD43 Expression in Differential Diagnosis between Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma.CD200和CD43表达在慢性淋巴细胞白血病与套细胞淋巴瘤鉴别诊断中的作用
Turk J Haematol. 2018 May 25;35(2):94-98. doi: 10.4274/tjh.2017.0085. Epub 2017 Jul 17.
6
Quantitative assessment of informative immunophenotypic markers increases the diagnostic value of immunophenotyping in mature CD5-positive B-cell neoplasms.定量评估有意义的免疫表型标志物可提高成熟 CD5 阳性 B 细胞肿瘤免疫表型诊断的价值。
Cytometry B Clin Cytom. 2018 Jul;94(4):576-587. doi: 10.1002/cyto.b.21607. Epub 2018 Jan 17.
7
[The immunophenotypic characteristics of 260 patients with CD5 + B cell lymphoproliferative disorders].[260例CD5 + B细胞淋巴增殖性疾病患者的免疫表型特征]
Zhonghua Xue Ye Xue Za Zhi. 2014 Apr;35(4):337-41. doi: 10.3760/cma.j.issn.0253-2727.2014.04.019.
8
Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project.通过流式细胞术实现慢性淋巴细胞白血病的可重现诊断:欧洲慢性淋巴细胞白血病研究倡议(ERIC)和欧洲临床细胞分析学会(ESCCA)的一项协调项目。
Cytometry B Clin Cytom. 2018 Jan;94(1):121-128. doi: 10.1002/cyto.b.21595. Epub 2018 Jan 17.
9
Diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200.慢性淋巴细胞白血病的诊断再探讨:采用包括CD200在内的改良五标记评分系统提高特异性
Br J Haematol. 2017 Nov;179(3):480-487. doi: 10.1111/bjh.14901. Epub 2017 Aug 18.
10
FMOD expression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot study.全血中 FMOD 的表达有助于鉴别慢性淋巴细胞白血病与其他白血病性淋巴增殖性疾病。一项初步研究。
Cytometry B Clin Cytom. 2020 Sep;98(5):421-428. doi: 10.1002/cyto.b.21890. Epub 2020 Jun 12.

引用本文的文献

1
Immunophenotypic properties association of CLL and ALL patient cells by flow cytometry analysis.通过流式细胞术分析慢性淋巴细胞白血病(CLL)和急性淋巴细胞白血病(ALL)患者细胞的免疫表型特性关联。
J Taibah Univ Med Sci. 2024 Sep 24;19(5):981-989. doi: 10.1016/j.jtumed.2024.09.008. eCollection 2024 Oct.
2
Chronic lymphocytic leukemia diagnosis: how many more algorithms and scoring systems do we need?慢性淋巴细胞白血病的诊断:我们还需要多少算法和评分系统?
Hematol Transfus Cell Ther. 2025 Jan-Mar;47(1):103668. doi: 10.1016/j.htct.2024.05.007. Epub 2024 Aug 3.
3
The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders.CD200 在 B 细胞淋巴增殖性疾病鉴别诊断中的应用。
Br J Biomed Sci. 2023 Sep 26;80:11573. doi: 10.3389/bjbs.2023.11573. eCollection 2023.
4
Atypical Chronic Lymphocytic Leukemia-The Current Status.非典型慢性淋巴细胞白血病——现状
Cancers (Basel). 2023 Sep 5;15(18):4427. doi: 10.3390/cancers15184427.
5
Targeting of Tetraspanin CD81 with Monoclonal Antibodies and Small Molecules to Combat Cancers and Viral Diseases.利用单克隆抗体和小分子靶向四跨膜蛋白CD81以对抗癌症和病毒性疾病
Cancers (Basel). 2023 Apr 6;15(7):2186. doi: 10.3390/cancers15072186.

本文引用的文献

1
Which Markers Should the used for Diagnostic Chronic Lymphocytic Leukemia Immunophenotyping Scoring System by Flow Cytometry?流式细胞术用于诊断慢性淋巴细胞白血病免疫表型评分系统时应使用哪些标志物?
Clin Lab. 2019 Nov 1;65(11). doi: 10.7754/Clin.Lab.2019.190316.
2
A decision-tree approach for the differential diagnosis of chronic lymphoid leukemias and peripheral B-cell lymphomas.用于慢性淋巴细胞白血病和外周 B 细胞淋巴瘤的鉴别诊断的决策树方法。
Comput Methods Programs Biomed. 2019 Sep;178:85-90. doi: 10.1016/j.cmpb.2019.06.014. Epub 2019 Jun 13.
3
Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment.慢性淋巴细胞白血病:2020 年诊断、风险分层和治疗更新。
Am J Hematol. 2019 Nov;94(11):1266-1287. doi: 10.1002/ajh.25595. Epub 2019 Oct 4.
4
CD81 Expression in the Differential Diagnosis of Chronic Lymphocytic Leukemia.CD81在慢性淋巴细胞白血病鉴别诊断中的表达
Clin Lab. 2019 Mar 1;65(3). doi: 10.7754/Clin.Lab.2018.180802.
5
CD200 is a useful diagnostic marker for identifying atypical chronic lymphocytic leukemia by flow cytometry.CD200是一种通过流式细胞术识别非典型慢性淋巴细胞白血病的有用诊断标志物。
Int J Lab Hematol. 2018 Oct;40(5):533-539. doi: 10.1111/ijlh.12857. Epub 2018 May 27.
6
CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia.包含在四标记改良马图斯评分中的CD200为慢性淋巴细胞白血病的诊断提供了最佳的敏感性和特异性。
Hematol Oncol. 2018 Mar 30. doi: 10.1002/hon.2510.
7
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL.iwCLL 指南:用于 CLL 的诊断、治疗指征、疗效评估和支持性管理。
Blood. 2018 Jun 21;131(25):2745-2760. doi: 10.1182/blood-2017-09-806398. Epub 2018 Mar 14.
8
Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project.通过流式细胞术实现慢性淋巴细胞白血病的可重现诊断:欧洲慢性淋巴细胞白血病研究倡议(ERIC)和欧洲临床细胞分析学会(ESCCA)的一项协调项目。
Cytometry B Clin Cytom. 2018 Jan;94(1):121-128. doi: 10.1002/cyto.b.21595. Epub 2018 Jan 17.
9
Quantitative flow cytometric evaluation of CD200, CD123, CD43 and CD52 as a tool for the differential diagnosis of mature B-cell neoplasms.流式细胞术定量评估CD200、CD123、CD43和CD52作为成熟B细胞肿瘤鉴别诊断工具的研究
Rev Bras Hematol Hemoter. 2017 Jul-Sep;39(3):252-258. doi: 10.1016/j.bjhh.2017.05.002. Epub 2017 May 29.
10
Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment.慢性淋巴细胞白血病:2017 年诊断、风险分层和治疗更新。
Am J Hematol. 2017 Sep;92(9):946-965. doi: 10.1002/ajh.24826.

一种使用流式细胞术免疫表型分析的慢性淋巴细胞白血病新型鉴别诊断算法。

A novel differential diagnosis algorithm for chronic lymphocytic leukemia using immunophenotyping with flow cytometry.

作者信息

Ozdemir Zehra Narli, Falay Mesude, Parmaksiz Ayhan, Genc Eylem, Beyler Ozlem, Gunes Ahmet Kursad, Ceran Funda, Dagdas Simten, Ozet Gulsum

机构信息

Ankara City Hospital, Ankara, Turkey.

Duzen Laboratories Group, Ankara, Turkey.

出版信息

Hematol Transfus Cell Ther. 2023 Apr-Jun;45(2):176-181. doi: 10.1016/j.htct.2021.08.012. Epub 2021 Nov 29.

DOI:10.1016/j.htct.2021.08.012
PMID:35216960
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10244248/
Abstract

INTRODUCTION

The availability of a clinical decision algorithm for diagnosis of chronic lymphocytic leukemia (CLL) may greatly contribute to the diagnosis of CLL, particularly in cases with ambiguous immunophenotypes. Herein we propose a novel differential diagnosis algorithm for the CLL diagnosis using immunophenotyping with flow cytometry.

METHODS

The hierarchical logistic regression model (Backward LR) was used to build a predictive algorithm for the diagnosis of CLL, differentiated from other lymphoproliferative disorders (LPDs).

RESULTS

A total of 302 patients, of whom 220 (72.8%) had CLL and 82 (27.2%), B-cell lymphoproliferative disorders other than CLL, were included in the study. The Backward LR model comprised the variables CD5, CD43, CD81, ROR1, CD23, CD79b, FMC7, sIg and CD200 in the model development process. The weak expression of CD81 and increased intensity of expression in markers CD5, CD23 and CD200 increased the probability of CLL diagnosis, (p < 0.05). The odd ratio for CD5, C23, CD200 and CD81 was 1.088 (1.050 - 1.126), 1.044 (1.012 - 1.077), 1.039 (1.007 - 1.072) and 0.946 (0.921 - 0.970) [95% C.I.], respectively. Our model provided a novel diagnostic algorithm with 95.27% of sensitivity and 91.46% of specificity. The model prediction for 97.3% (214) of 220 patients diagnosed with CLL, was CLL and for 91.5% (75) of 82 patients diagnosed with an LPD other than CLL, was others. The cases were correctly classified as CLL and others with a 95.7% correctness rate.

CONCLUSIONS

Our model highlighting 4 markers (CD81, CD5, CD23 and CD200) provided high sensitivity and specificity in the CLL diagnosis and in distinguishing of CLL among other LPDs.

摘要

引言

慢性淋巴细胞白血病(CLL)临床诊断算法的可用性可能极大地有助于CLL的诊断,特别是在免疫表型不明确的病例中。在此,我们提出一种使用流式细胞术免疫表型分析的新型CLL诊断鉴别算法。

方法

采用分层逻辑回归模型(向后LR)构建用于诊断CLL的预测算法,以区别于其他淋巴增殖性疾病(LPD)。

结果

本研究共纳入302例患者,其中220例(72.8%)患有CLL,82例(27.2%)患有除CLL以外的B细胞淋巴增殖性疾病。在模型开发过程中,向后LR模型包含变量CD5、CD43、CD81、ROR1、CD23、CD79b、FMC7、sIg和CD200。CD81的弱表达以及CD5、CD23和CD200标记物表达强度的增加增加了CLL诊断的可能性(p < 0.05)。CD5、C23、CD200和CD81的比值比分别为1.088(1.050 - 1.126)、1.044(1.012 - 1.077)、1.039(1.007 - 1.072)和0.946(0.921 - 0.970)[95%置信区间]。我们的模型提供了一种新型诊断算法,灵敏度为95.27%,特异性为91.46%。在220例诊断为CLL的患者中,该模型对97.3%(214例)的预测为CLL,在82例诊断为除CLL以外的LPD的患者中,对91.5%(75例)的预测为其他疾病。这些病例被正确分类为CLL和其他疾病,正确率为95.7%。

结论

我们突出4种标记物(CD81、CD5、CD23和CD200)的模型在CLL诊断以及在其他LPD中鉴别CLL方面提供了高灵敏度和特异性。